Recombinant factor VIIa (NovoSeven®) as a hemostatic agent

被引：59

作者：

Hedner, U

机构：

[1] Novo Nordisk AS, Res & Dev, Malov, Denmark

[2] Lund Univ, Wallenblig Res Lab Malmo, Lund, Sweden

来源：

SEMINARS IN HEMATOLOGY | 2001年 / 38卷 / 04期

关键词：

D O I：

10.1016/S0037-1963(01)90147-7

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：43 / 47

页数：5

共 45 条

[1]

ABERG M, 1978, ANN SURG, V189, P243

[2]

BAJZAR L, 1993, J BIOL CHEM, V268, P8608

[3]

BECH R, 1989, THROMB HAEMOSTASIS, V62, P55

[4]

Beguin S, 1997, THROMB HAEMOSTASIS, V78, P590

[5]

BEGUIN S, 1989, THROMB HAEMOSTASIS, V61, P25

[6] Recombinant factor VIIa corrects prothrombin time in cirrhotic patients: A preliminary study [J].

Bernstein, DE ;

Jeffers, L ;

Erhardtsen, E ;

Reddy, KR ;

Glazer, S ;

Squiban, P ;

Bech, R ;

Hedner, U ;

Schiff, ER .

GASTROENTEROLOGY, 1997, 113 (06) :1930-1937

[7] NovoSeven® in warfarin-treated patients [J].

Berntorp, E ;

Stigendal, L ;

Lethagen, S ;

Olofsson, L ;

Hedner, U .

BLOOD COAGULATION & FIBRINOLYSIS, 2000, 11 :S113-S115

[8]

BIGGS R, 1962, HUMAN BLOOD COAGULAT

[9] FIBRIN IN HUMAN PLASMA - GEL ARCHITECTURES GOVERNED BY RATE AND NATURE OF FIBRINOGEN ACTIVATION [J].

BLOMBACK, B ;

CARLSSON, K ;

FATAH, K ;

HESSEL, B ;

PROCYK, R .

THROMBOSIS RESEARCH, 1994, 75 (05) :521-538

[10] Coagulation-dependent inhibition of fibrinolysis: Role of carboxypeptidase-U and the premature lysis of clots from hemophilic plasma [J].

Broze, GJ ;

Higuchi, DA .

BLOOD, 1996, 88 (10) :3815-3823

← 1 2 3 4 5 →